TARGETING NUCLEAR FGF RECEPTOR TO IMPROVE CHEMOTHERAPY RESPONSE IN TRIPLE-NEGATIVE BREAST CANCER

$586,183FY2013Department of the ArmyDOD

Duke University, Durham NC

Investigators